Annual D&A
$18.59 M
+$6.10 M+48.84%
September 30, 2024
Summary
- As of February 12, 2025, ARWR annual depreciation & amortization is $18.59 million, with the most recent change of +$6.10 million (+48.84%) on September 30, 2024.
- During the last 3 years, ARWR annual D&A has risen by +$10.33 million (+124.93%).
- ARWR annual D&A is now at all-time high.
Performance
ARWR Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$5.03 M
+$243.00 K+5.08%
September 30, 2024
Summary
- As of February 12, 2025, ARWR quarterly depreciation & amortization is $5.03 million, with the most recent change of +$243.00 thousand (+5.08%) on September 30, 2024.
- Over the past year, ARWR quarterly D&A has increased by +$500.00 thousand (+11.05%).
- ARWR quarterly D&A is now at all-time high.
Performance
ARWR Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$18.59 M
+$1.17 M+6.69%
September 30, 2024
Summary
- As of February 12, 2025, ARWR TTM depreciation & amortization is $18.59 million, with the most recent change of +$1.17 million (+6.69%) on September 30, 2024.
- Over the past year, ARWR TTM D&A has increased by +$2.67 million (+16.78%).
- ARWR TTM D&A is now at all-time high.
Performance
ARWR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ARWR Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.8% | +11.1% | +16.8% |
| 3 y3 years | +124.9% | +100.7% | +124.9% |
| 5 y5 years | +318.9% | +100.7% | +124.9% |
ARWR Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +124.9% | at high | +95.3% | at high | +106.8% |
| 5 y | 5-year | at high | +318.9% | at high | +298.8% | at high | +311.3% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Arrowhead Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | $18.59 M(+48.8%) | $5.03 M(+5.1%) | $18.59 M(+6.7%) |
| Jun 2024 | - | $4.78 M(+5.7%) | $17.43 M(+9.5%) |
| Mar 2024 | - | $4.53 M(+6.1%) | $15.92 M(+13.2%) |
| Dec 2023 | - | $4.26 M(+10.5%) | $14.07 M(+12.6%) |
| Sep 2023 | $12.49 M(+19.9%) | $3.86 M(+17.8%) | $12.49 M(+10.6%) |
| Jun 2023 | - | $3.28 M(+22.7%) | $11.29 M(+6.4%) |
| Mar 2023 | - | $2.67 M(-0.7%) | $10.61 M(+0.7%) |
| Dec 2022 | - | $2.69 M(+1.1%) | $10.54 M(+1.1%) |
| Sep 2022 | $10.42 M(+26.1%) | $2.66 M(+2.5%) | $10.42 M(+1.5%) |
| Jun 2022 | - | $2.59 M(0.0%) | $10.27 M(+6.2%) |
| Mar 2022 | - | $2.59 M(+0.8%) | $9.67 M(+7.5%) |
| Dec 2021 | - | $2.57 M(+2.8%) | $8.99 M(+8.8%) |
| Sep 2021 | $8.27 M(+39.1%) | $2.50 M(+25.4%) | $8.27 M(+9.7%) |
| Jun 2021 | - | $2.00 M(+4.1%) | $7.54 M(+6.5%) |
| Mar 2021 | - | $1.92 M(+3.8%) | $7.08 M(+8.4%) |
| Dec 2020 | - | $1.85 M(+4.2%) | $6.53 M(+9.9%) |
| Sep 2020 | $5.94 M(+33.9%) | $1.77 M(+15.5%) | $5.94 M(+13.2%) |
| Jun 2020 | - | $1.54 M(+12.0%) | $5.25 M(+11.3%) |
| Mar 2020 | - | $1.37 M(+8.9%) | $4.72 M(+4.3%) |
| Dec 2019 | - | $1.26 M(+16.4%) | $4.52 M(+1.9%) |
| Sep 2019 | $4.44 M(-5.5%) | $1.08 M(+7.9%) | $4.44 M(-3.2%) |
| Jun 2019 | - | $1.00 M(-14.7%) | $4.59 M(-3.6%) |
| Mar 2019 | - | $1.18 M(-0.1%) | $4.76 M(+0.5%) |
| Dec 2018 | - | $1.18 M(-4.2%) | $4.74 M(+0.8%) |
| Sep 2018 | $4.70 M(+0.2%) | $1.23 M(+4.4%) | $4.70 M(+1.6%) |
| Jun 2018 | - | $1.18 M(+2.0%) | $4.63 M(+0.3%) |
| Mar 2018 | - | $1.15 M(+1.1%) | $4.61 M(-0.7%) |
| Dec 2017 | - | $1.14 M(-1.2%) | $4.65 M(-0.9%) |
| Sep 2017 | $4.69 M(+43.9%) | $1.15 M(-0.7%) | $4.69 M(+7.1%) |
| Jun 2017 | - | $1.16 M(-2.1%) | $4.38 M(+8.5%) |
| Mar 2017 | - | $1.19 M(+0.2%) | $4.04 M(+10.5%) |
| Dec 2016 | - | $1.19 M(+40.5%) | $3.65 M(+12.0%) |
| Sep 2016 | $3.26 M(+39.5%) | $843.60 K(+3.1%) | $3.26 M(-0.4%) |
| Jun 2016 | - | $818.20 K(+1.8%) | $3.27 M(+2.4%) |
| Mar 2016 | - | $803.90 K(+1.2%) | $3.19 M(+12.5%) |
| Dec 2015 | - | $794.30 K(-7.2%) | $2.84 M(+21.6%) |
| Sep 2015 | $2.34 M(+73.6%) | $855.60 K(+15.5%) | $2.34 M(+33.4%) |
| Jun 2015 | - | $741.10 K(+64.8%) | $1.75 M(+36.2%) |
| Mar 2015 | - | $449.60 K(+55.0%) | $1.29 M(+4.4%) |
| Dec 2014 | - | $290.00 K(+7.2%) | $1.23 M(-8.4%) |
| Sep 2014 | $1.35 M(-23.2%) | $270.40 K(-2.1%) | $1.35 M(-8.7%) |
| Jun 2014 | - | $276.10 K(-30.2%) | $1.47 M(-10.8%) |
| Mar 2014 | - | $395.80 K(-1.9%) | $1.65 M(-3.1%) |
| Dec 2013 | - | $403.40 K(+1.1%) | $1.71 M(-2.6%) |
| Sep 2013 | $1.75 M(+0.1%) | $399.00 K(-12.1%) | $1.75 M(-2.7%) |
| Jun 2013 | - | $454.10 K(+1.2%) | $1.80 M(+1.7%) |
| Mar 2013 | - | $448.80 K(-0.2%) | $1.77 M(+1.4%) |
| Dec 2012 | - | $449.60 K(+0.5%) | $1.74 M(-0.3%) |
| Sep 2012 | $1.75 M | $447.20 K(+5.6%) | $1.75 M(+28.0%) |
| Jun 2012 | - | $423.40 K(-0.1%) | $1.37 M(+35.3%) |
| Mar 2012 | - | $423.90 K(-6.7%) | $1.01 M(+54.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | - | $454.40 K(+600.2%) | $653.60 K(+143.9%) |
| Sep 2011 | $268.00 K(-3.5%) | $64.90 K(-2.4%) | $268.00 K(-1.2%) |
| Jun 2011 | - | $66.50 K(-1.9%) | $271.30 K(-0.9%) |
| Mar 2011 | - | $67.80 K(-1.5%) | $273.80 K(+59.0%) |
| Dec 2010 | - | $68.80 K(+0.9%) | $172.20 K(-38.0%) |
| Sep 2010 | $277.70 K(-72.1%) | $68.20 K(-1.2%) | $277.70 K(-32.5%) |
| Jun 2010 | - | $69.00 K(-304.1%) | $411.60 K(-32.3%) |
| Mar 2010 | - | -$33.80 K(-119.4%) | $608.30 K(-31.0%) |
| Dec 2009 | - | $174.30 K(-13.8%) | $881.60 K(-11.4%) |
| Sep 2009 | $994.60 K(-12.2%) | $202.10 K(-23.9%) | $994.70 K(-7.6%) |
| Jun 2009 | - | $265.70 K(+10.9%) | $1.08 M(-0.1%) |
| Mar 2009 | - | $239.50 K(-16.7%) | $1.08 M(-5.1%) |
| Dec 2008 | - | $287.40 K(+1.3%) | $1.14 M(+0.2%) |
| Sep 2008 | $1.13 M(+12.9%) | $283.60 K(+6.2%) | $1.13 M(-0.2%) |
| Jun 2008 | - | $267.00 K(-10.3%) | $1.14 M(+1.3%) |
| Mar 2008 | - | $297.50 K(+4.3%) | $1.12 M(+6.0%) |
| Dec 2007 | - | $285.20 K(-0.3%) | $1.06 M(+5.4%) |
| Sep 2007 | $1.00 M(+13.2%) | $286.20 K(+13.3%) | $1.00 M(+3.5%) |
| Jun 2007 | - | $252.60 K(+7.7%) | $969.80 K(+2.4%) |
| Mar 2007 | - | $234.50 K(+1.7%) | $946.70 K(+6.5%) |
| Dec 2006 | - | $230.60 K(-8.5%) | $889.10 K(+0.2%) |
| Sep 2006 | $887.00 K(+37.7%) | $252.10 K(+9.8%) | $887.00 K(+1.6%) |
| Jun 2006 | - | $229.50 K(+29.7%) | $873.00 K(+9.9%) |
| Mar 2006 | - | $176.90 K(-22.6%) | $794.50 K(+3.8%) |
| Dec 2005 | - | $228.50 K(-4.0%) | $765.10 K(+18.8%) |
| Sep 2005 | $644.00 K(+762.1%) | $238.10 K(+57.7%) | $644.00 K(+34.6%) |
| Jun 2005 | - | $151.00 K(+2.4%) | $478.40 K(+45.4%) |
| Mar 2005 | - | $147.50 K(+37.3%) | $329.10 K(+80.9%) |
| Dec 2004 | - | $107.40 K(+48.1%) | $181.90 K(+143.5%) |
| Sep 2004 | $74.70 K(>+9900.0%) | $72.50 K(+4164.7%) | $74.70 K(-2767.9%) |
| Jun 2004 | - | $1700.00(+466.7%) | -$2800.00(0.0%) |
| Mar 2004 | - | $300.00(+50.0%) | -$2800.00(+100.0%) |
| Dec 2003 | - | $200.00(-104.0%) | -$1400.00(-1500.0%) |
| Sep 2003 | $100.00(-98.9%) | -$5000.00(-394.1%) | $100.00(-98.9%) |
| Jun 2003 | - | $1700.00(0.0%) | $9100.00(-26.6%) |
| Mar 2003 | - | $1700.00(0.0%) | $12.40 K(+14.8%) |
| Dec 2002 | - | $1700.00(-57.5%) | $10.80 K(+18.7%) |
| Sep 2002 | $9100.00(+160.0%) | $4000.00(-20.0%) | $9100.00(+102.2%) |
| Jun 2002 | - | $5000.00(+4900.0%) | $4500.00(-1000.0%) |
| Mar 2002 | - | $100.00(>+9900.0%) | -$500.00(-141.7%) |
| Dec 2001 | - | $0.00(-100.0%) | $1200.00(-65.7%) |
| Sep 2001 | $3500.00(-53.9%) | -$600.00(<-9900.0%) | $3500.00(-36.4%) |
| Jun 2001 | - | $0.00(-100.0%) | $5500.00(-27.6%) |
| Mar 2001 | - | $1800.00(-21.7%) | $7600.00(-3.8%) |
| Dec 2000 | - | $2300.00(+64.3%) | $7900.00(+2.6%) |
| Sep 2000 | $7600.00(-6.2%) | $1400.00(-33.3%) | $7700.00(+22.2%) |
| Jun 2000 | - | $2100.00(0.0%) | $6300.00(+50.0%) |
| Mar 2000 | - | $2100.00(0.0%) | $4200.00(+100.0%) |
| Dec 1999 | - | $2100.00 | $2100.00 |
| Sep 1999 | $8100.00(-12.0%) | - | - |
| Sep 1998 | $9200.00(-91.1%) | - | - |
| Sep 1997 | $103.80 K | - | - |
FAQ
- What is Arrowhead Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual D&A year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly D&A year-on-year change?
- What is Arrowhead Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals TTM D&A year-on-year change?
What is Arrowhead Pharmaceuticals annual depreciation & amortization?
The current annual D&A of ARWR is $18.59 M
What is the all time high annual D&A for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual depreciation & amortization is $18.59 M
What is Arrowhead Pharmaceuticals annual D&A year-on-year change?
Over the past year, ARWR annual depreciation & amortization has changed by +$6.10 M (+48.84%)
What is Arrowhead Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of ARWR is $5.03 M
What is the all time high quarterly D&A for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly depreciation & amortization is $5.03 M
What is Arrowhead Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, ARWR quarterly depreciation & amortization has changed by +$500.00 K (+11.05%)
What is Arrowhead Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of ARWR is $18.59 M
What is the all time high TTM D&A for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high TTM depreciation & amortization is $18.59 M
What is Arrowhead Pharmaceuticals TTM D&A year-on-year change?
Over the past year, ARWR TTM depreciation & amortization has changed by +$2.67 M (+16.78%)